EPO Patents = 2

Forward Citations = 41

Loading Chart...

9 inventors (with patents filed for the assignee):

Jerod Ptacin (12 out of 13 patents)

Carolina E Caffaro (12 out of 13 patents)

Marcos Milla (10 out of 11 patents)

4. Aaron W Feldman (2 out of 5 patents)

5. Floyd E Romesberg (2 out of 24 patents)

6. Yorke Zhang (2 out of 7 patents)

7. Hans Aerni (2 out of 2 patents)

8. Emil C Fischer (2 out of 2 patents)

9. Vivian T Dien (2 out of 4 patents)

12 patents: Sort by Forward Citations

1. 12521437 - IL-2 Conjugates and Methods of Use Thereof (2026-01-13),

2. 12491254 - INTERLEUKIN 10 CONJUGATES AND USES THEREOF (2025-12-09),

3. 12377131 - Cytokine conjugates for the treatment of autoimmune diseases (2025-08-05),

4. 12319944 - Incorporation of unnatural nucleotides and methods thereof (2025-06-03),

5. 12318431 - Cytokine conjugates for the treatment of proliferative and infectious diseases (2025-06-03),

6. 12234271 - Il-2 conjugates and methods of use to treat autoimmune diseases (2025-02-25),

7. 11919934 - IL-15 conjugates and uses thereof (2024-03-05),

8. 11834689 - Incorporation of unnatural nucleotides and methods thereof (2023-12-05),

9. 11701407 - Cytokine conjugates for the treatment of proliferative and infectious diseases (2023-07-18),

10. 11622993 - Cytokine conjugates for the treatment of autoimmune diseases (2023-04-11),

11. 11077195 - IL-2 conjugates and methods of use thereof (2021-08-03),

12. 10610571 - Cytokine conjugates for the treatment of proliferative and infectious diseases (2020-04-07),

Company Overview

Synthorx, Inc. is a biotechnology company based in La Jolla, California, specializing in the development of innovative protein therapeutics. The company focuses on expanding the genetic code to create synthetic amino acids, which allows for the design of proteins with enhanced properties and functionalities. Synthorx's research is primarily centered on applications in oncology and autoimmune diseases, aiming to improve treatment options and patient outcomes through advanced therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#34 in La Jolla, CA

#6,060 in California

#25,471 in US

#48,129 in the World

La Jolla, CA, United States of America

Synthorx, Inc.

Forward Citations = 41

9 inventors:

Jerod Ptacin (12 out of 13 patents)

Carolina E Caffaro (12 out of 13 patents)

Marcos Milla (10 out of 11 patents)

4. Aaron W Feldman (2 out of 5 patents)

5. Floyd E Romesberg (2 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synthorx, Inc.. Retrieved from https://idiyas.com/company/synthorx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]